Metabolic disposition of tacrine in primary suspensions of rat hepatocyte and in single-pass perfused liver:in vitro/in vivocomparisons
- 1 January 1994
- journal article
- research article
- Published by Taylor & Francis in Xenobiotica
- Vol. 24 (11) , 1107-1117
- https://doi.org/10.3109/00498259409038670
Abstract
1. Incubations of tacrine (1,2,3,4-tetrahydro-9-acridinamine monohydrochloride monohydrate, THA) with a primary suspension of rat hepatocytes for 2 min resulted in formation of the 1-hydroxy derivative as the major metabolite with smaller amounts of the 2- and 4-hydroxy metabolites. 2. Apparent Vmax and Km for THA metabolism were 12.4 +/- 3.3 nmol/min/g liver and 0.98 +/- 0.34 microM respectively. 3. Incubations of THA for longer time-periods (> 10 min) resulted in irreversible binding of THA-derived radioactivity to hepatocellular protein. The apparent maximal rate of irreversible binding (Bmax) was 76.7 +/- 30.5 pmol equivalents bound/h/mg cell protein, whereas the apparent Kb for binding was 2.8 +/- 1.4 microM. 4. The kinetic parameters, Vmax and Km, were used to predict steady-state extraction ratios (ERSS) for various THA input concentrations (Cin) in single-pass perfused rat liver. At low input concentrations (0.72-0.85 microM; Cin < Km), ERSS of THA was approximately 1. For higher Cin (14.05, 20.72, 20.88 microM; Cin >> Km), the calculated ERSS was markedly decreased with 0.300, 0.296 and 0.261, respectively. 5. The intrinsic clearance of THA (Cli) estimated from in vitro hepatocyte data was 6.7 ml/min/g liver while the apparent oral THA clearance (Cloral) calculated from in vivo rat data was 6.6 ml/min/g liver.Keywords
This publication has 14 references indexed in Scilit:
- The effect of enzyme inhibition on the metabolism and activation of tacrine by human liver microsomes.British Journal of Clinical Pharmacology, 1994
- A 30-Week Randomized Controlled Trial of High-Dose Tacrine in Patients With Alzheimer's DiseaseJAMA, 1994
- An investigation into the formation of stable, protein-reactive and cytotoxic metabolites from tacrine in vitro: Studies with human and rat liver microsomesBiochemical Pharmacology, 1993
- A Controlled Trial of Tacrine in Alzheimer's DiseaseJAMA, 1992
- Effects of Tetrahydroaminoacridine on Liver Function in Patients with Alzheimer's DiseaseAge and Ageing, 1991
- Clinical pharmacokinetics of intravenous and oral 9-amino-1,2,3,4-tetrahydroacridine, tacrineEuropean Journal of Clinical Pharmacology, 1990
- Immune mechanisms in tienilic acid associated hepatotoxicity.Gut, 1989
- [3] The use of perfusion of liver and other organs for the study of microsomal electron-transport and cytochrome P-450 systemsPublished by Elsevier ,1978
- Hepatic clearance of drugs. I. Theoretical considerations of a “well-stirred” model and a “parallel tube” model. Influence of hepatic blood flow, plasma and blood cell binding, and the hepatocellular enzymatic activity on hepatic drug clearanceJournal of Pharmacokinetics and Biopharmaceutics, 1977
- Chapter 4 Preparation of Isolated Rat Liver CellsPublished by Elsevier ,1976